Wong stated that this medication is now in the third phase of clinical trials, which are expected to be completed within three years, with a 90 % expectation of success.
翁啟惠表示，此一愛滋新藥已到第三期臨床試驗階段，預計 3 年內完成，且成功機率高達 9 成。